MedTrace Logo

Evaluation of the "Pupillary Pain Index" in Neurological Prognosis After Cardiac Arrest

NCT04336930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-05-24

No results posted yet for this study

Summary

Two-thirds of patients admitted to the Intensive Care Unit after a cardiac arrest die in the context of treatment withdrawal after a multimodal evaluation that determines an unfavorable neurological outcome.

This study will evaluate the Pupillary Pain Index (PPI) in the neurological prognosis after cardiac arrest. The PPI is determined by recording of pupillary dilatation with a videopupillometer after a calibrated and incremented nociceptive stimulus on a cutaneous metamere.

Conditions

  • Cardiac Arrest
  • Post-Anoxic Coma
  • Anoxic Brain Injury

Interventions

DIAGNOSTIC_TEST

Pupillary pain index (PPI)

Measurement of PPI with a pupillometer

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Matthieu Koszutski, Dr · Nancy Teaching Hospital, CHU de Nancy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-12-31
Completion
2023-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04336930 on ClinicalTrials.gov